Back

Specific MMP-9 and MMP-2 inhibition by novel MMP antibody attenuates LV remodeling secondary to volume overload

26 August 2018 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Cardiac remodelling Drugs, Drug Targets ESC Premium Access ESC Congress 2018

About the speaker

Photo
Mrs Lena Cohen

Tel Aviv Sourasky Medical Center, Tel Aviv (Israel)

9 More presentations in this session

Presentation thumbnail
Associate Professor M. Nader (Riyadh, SA)
Abstract
Presentation thumbnail
Doctor I. Kopaliani (Dresden, DE)
Abstract
Presentation thumbnail
Doctor T. Takahashi (Yamagata, JP)
Abstract
Presentation thumbnail
Mr N. Boccella (Napoly, IT)
Abstract
Presentation thumbnail
Mr K. Okabe (Fukuoka, JP)
Abstract

Access the full session

Session thumbnail
Poster Session 3 - Cardiac remodelling

The Event

Event poster

ESC Congress 2018

26 August 2018 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Matrix metallopeptidase-9 association with heart failure development in STEMI patients after percutaneous coronary intervention in one-year follow-up period
12 May 2024
thumbnail
Congress Presentation
Interleukin-22 inhibits right ventricular remodelling by a unique mechanism in a pulmonary artery constriction model.
30 August 2024
thumbnail
Congress Presentation
Reduction of extracellular volume and reverse cardiac remodeling during sacubitril/valsartan therapy assessed by cardiac magnetic resonance in patients with heart failure (REMODELING CMR-HF)
6 May 2021
thumbnail
Congress Presentation
Klotho protein inhibits extracellular matrix degradation and apoptosis during heart ischemia/reperfusion injury via regulation of the NOS/MMP signalling axis
25 April 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources